SCHEMBL332285

SCHEMBL332285

Cc1cccc(-c2ccccc2Nc2cc(Nc3ccccc3-c3cccc(C)c3)cc(Nc3ccccc3-c3cccc(C)c3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.44
ADORA1 P30542 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.42
PLA2G1B P04054 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
CHRM3 P20309 5/20 0.41
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
ADORA2A P29274 1/20 0.40
ENPP3 O14638 1/20 0.39
CNR2 P34972 2/20 0.39
CNR1 P21554 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246941 0.91 NPSR1 (0.56) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL130522 0.90 NPSR1 (0.46) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL2294636 0.87 FABP3 (0.50) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL1505781 0.87 NPSR1 (0.43) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL7865722 0.85 MAPT (0.44) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL7716047 0.84 NPSR1 (0.41) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL7875133 0.84 MEN1 (0.52) NPSR1L3MBTL1MEN1KMT2AMAPT
SCHEMBL1492925 0.84 NPSR1 (0.41) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL6081498 0.84 NPSR1 (0.41) NPSR1ADORA1L3MBTL1MEN1ALDH1A1
SCHEMBL7717151 0.84 NPSR1 (0.41) NPSR1ADORA1L3MBTL1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12581795-B2 Display device and method for manufacturing same SHARP KABUSHIKI KAISHA (JP) 2026-03-17 US claimed
US-12495665-B2 Display device having carrier blocking section between pixels SHARP KABUSHIKI KAISHA (JP) 2025-12-09 US claimed
US-12453281-B2 Functional material, light-emitting substrate and manufacturing method therefor, and light-emitting apparatus Beijing Boe Technology Development Co., Ltd. (CN) 2025-10-21 US claimed
US-20230389392-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME SHARP KABUSHIKI KAISHA (JP) 2023-11-30 US claimed
US-20230354698-A1 FUNCTIONAL MATERIAL, LIGHT-EMITTING SUBSTRATE AND MANUFACTURING METHOD THEREFOR, AND LIGHT-EMITTING APPARATUS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-11-02 US claimed
US-20230309334-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME SHARP KABUSHIKI KAISHA (JP) 2023-09-28 US claimed
US-12581795-B2 Display device and method for manufacturing same SHARP KABUSHIKI KAISHA (JP) 2026-03-17 US disclosed
US-12495665-B2 Display device having carrier blocking section between pixels SHARP KABUSHIKI KAISHA (JP) 2025-12-09 US disclosed
US-12453281-B2 Functional material, light-emitting substrate and manufacturing method therefor, and light-emitting apparatus Beijing Boe Technology Development Co., Ltd. (CN) 2025-10-21 US disclosed
US-12178060-B2 Electroluminescent device, method for manufacturing the same, display panel and display device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2024-12-24 US disclosed
US-12165816-B2 Perovskite solar cell with silicon dioxide antireflection layer KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-12-10 US disclosed
US-12106909-B2 Solar cell antireflection and porous silicon layers KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-10-01 US disclosed
US-12100562-B2 Solar cell with alumina coated porous silicon layer KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-09-24 US disclosed
US-20120083070-A1 CHARGE INJECTION AND TRANSPORT LAYERS PLEXTRONICS, INC. 2012-04-05 US disclosed
US-8097876-B2 Charge injection and transport layers PLEXTRONICS, INC. (US) 2012-01-17 US disclosed
EP-2350216-A1 CHARGE INJECTION AND TRANSPORT LAYERS Plextronics, Inc. (US) 2011-08-03 EP disclosed
US-20100270924-A1 FLEXIBLE LIGHT EMITTING/CHARGE STORAGE DEVICE AND SYSTEM AUTHENTX, INC. 2010-10-28 US disclosed
WO-2010062558-A1 CHARGE INJECTION AND TRANSPORT LAYERS PLEXTRONICS INC. (US) 2010-06-03 WO disclosed
US-20100109000-A1 CHARGE INJECTION AND TRANSPORT LAYERS PLEXTRONICS, INC. 2010-05-06 US disclosed
US-20090256117-A1 DOPED CONJUGATED POLYMERS, DEVICES, AND METHODS OF MAKING DEVICES PLEXTRONICS, INC. 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12581795-B2 Display device and method for manufacturing same EPHA4, NECTIN4, L1CAM NPSR1 2567/4885ADORA1 1608/4885L3MBTL1 362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.